BioMérieux S.A. BioMérieux S.A.

BioMérieux S.A.

BIM

Rankning i aktier #1799
bioMérieux S.A. is a global entity operating across the Americas, Europe, the... bioMérieux S.A. is a global entity operating across the Americas, Europe, the Middle East, Africa, and the Asia Pacific, specializing in the development and production of in vitro diagnostic solutions. The company's sophisticated systems utilize biological samples to identify infectious diseases, cardiovascular conditions, and various forms of cancer. Additionally, bioMérieux provides essential microbiological testing services for the manufacturing sectors, primarily serving the food, pharmaceutical, cosmetics, and veterinary industries. Its client base includes clinical and hospital laboratories, medical practitioners, blood banks, and industrial quality control facilities. Founded in 1963, originally under the name B-D Mérieux, bioMérieux S.A. maintains its headquarters in Marcy l'Etoile, France, and functions as a subsidiary of Institut Mérieux SA.
Aktiekurs
$98.71
Marknadsvärde
$11.62B
Förändring (1 dag)
1.91%
Förändring (1 år)
-25.24%
Land
FR
Handel BioMérieux S.A. (BIM)

Kategori

Healthcare
Aktiekurshistorik för BioMérieux S.A. (BIM)
Högsta slutkurs: $98.28 den 2026-10-01

Lägsta slutkurs: $0.47 den 2002-01-01
Aktiekurshistorik för BioMérieux S.A. från 2002 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) -18.12%
2025 19.87%
2024 -3.27%
2023 5.35%
2022 -25.68%
2021 -2.88%
2020 58.83%
2019 32.64%
2018 -22.37%
2017 80.30%
2016 23.79%
2015 11.80%
2014 2.43%
2013 10.36%
2012 25.01%
2011 -23.88%
2010 -18.81%
2009 50.69%
2008 -29.44%
2007 68.49%
2006 33.52%
2005 27.00%
2004 105,745.40%
2003 -98.59%
2002 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$677.23 19.40%
US
$229.38 5.17%
US
$398.14 111.75%
US
$21.16 49.45%
CN
$173.17 18.72%
US